Katherine Lake, BA

UT Southwestern Medical School
Dallas, TX

Disclosures:

• Employment: none
• Compensation: none
• Ownership: none
• Leadership: none

Presentation(s):

• 3394 - Ultra-Low-Dose Adaptive Radiotherapy and Single-Agent Rituximab for Indolent Non-Hodgkin Lymphomas: Where Less is More in Combined Modality Therapy

  Tuesday, October 1, 2024
  4:00 PM – 5:00 PM ET